enzastaurin

Showing 1 posts of 1 posts found.

Lilly image

Lilly takes $30m hit

May 13, 2013
Research and Development, Sales and Marketing enzastaurin, lilly

Eli Lilly has taken a $30 million hit after abandoning late-stage development of its investigational cancer drug enzastaurin. The compound …

The Gateway to Local Adoption Series

Latest content